金陵药业：福州梅峰制药厂的水解蛋白注射液获得药品再注册批准通知书

Core Viewpoint - Jinling Pharmaceutical (000919.SZ) has received a drug re-registration approval notice from the Fujian Provincial Drug Administration for its hydrolyzed protein injection, indicating a positive regulatory development for the company [1] Company Summary - Jinling Pharmaceutical's subsidiary, Fuzhou Meifeng Pharmaceutical Factory, has been granted approval for the hydrolyzed protein injection, which is a sterilized solution of hydrolyzed casein and whey protein with sorbitol [1] - The hydrolyzed protein injection is primarily used for severe amino acid deficiency caused by serious surgical trauma and extensive burns, as well as for hypoproteinemia resulting from various diseases [1]